Ira M. Jacobson, M.D., the lead investigator of the ADVANCE trial, reported breakthrough findings at the 61st Annual Meeting of the American Association for the Study of Liver Disease in Boston on November 2, 2010. Adding a protease inhibitor – telaprevir – to the standard first-time treatment given to patients with hepatitis C resulted in a superior success rate.
Physicians from The Jay Monahan Center for Gastrointestinal Health at NewYork-Presbyterian/Weill Cornell Medical Center will reveal the most-up-to-date information on colorectal cancer screening guidelines, risk factors, and risk reduction. In addition, Katie Couric will be on hand to answer questions regarding colorectal cancer and the importance of screening, early detection, and prevention.
The AAP, founded in 1885, annually recognizes 55 individuals who have attained preeminence in medical research. Elected members have included Nobel laureates and members of the National Academy of Science, and encompass all field of medicine.
The American Liver Foundation, the nation's leading nonprofit organization for liver health promotion and disease prevention, has named Dr. Ira M. Jacobson as their Physician of the Year Award Recipient. He will be honored on September 27, 2007 at the Flavors of New York Culinary Gala at the Pierre Hotel.
